We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The Pharmaceutical Research and Manufacturers of America (PhRMA) has initiated litigation in the United States District Court for the Eastern District of California challenging SB 17.